SCHEMBL15020007

SCHEMBL15020007

Cn1cc(CCc2ccc(F)cc2)c2cc(C(=O)NO)ccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HASPIN Q8TF76 9/20 0.57
PDPK1 O15530 1/20 0.55
CHEK2 O96017 1/20 0.55
ABL1 P00519 1/20 0.55
EGFR P00533 1/20 0.55
ERBB2 P04626 1/20 0.55
NTRK1 P04629 1/20 0.55
MET P08581 1/20 0.55
PDGFRB P09619 1/20 0.55
KIT P10721 1/20 0.55
FGFR1 P11362 1/20 0.55
SRC P12931 1/20 0.55
PDGFRA P16234 1/20 0.55
FLT1 P17948 1/20 0.55
CSNK2A2 P19784 1/20 0.55
FGFR2 P21802 1/20 0.55
FGFR4 P22455 1/20 0.55
FGFR3 P22607 1/20 0.55
MAPK3 P27361 1/20 0.55
MAPK1 P28482 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1992307 0.89 HASPIN (0.56) HASPINPDPK1CHEK2ABL1EGFR
SCHEMBL1993367 0.78 HASPIN (0.47) HASPINSNCAHDAC6HDAC1HDAC3
SCHEMBL4255197 0.76 HASPIN (0.47) HASPINPDPK1CHEK2ABL1EGFR
SCHEMBL5458138 0.75 HASPIN (0.51) HASPINPDPK1CHEK2ABL1EGFR
SCHEMBL1992602 0.74 CDK2 (0.44) HASPINRXFP1SNCAMEN1KMT2A
SCHEMBL15039164 0.73 SCN9A (0.49) HDAC6HDAC1HDAC3HDAC8HDAC2
SCHEMBL1994556 0.73 HASPIN (0.61) HASPINPDPK1CHEK2ABL1EGFR
SCHEMBL12607920 0.72 MTNR1A (0.50) HASPINHDAC6HDAC1HDAC3HDAC8
SCHEMBL23809233 0.70 HDAC6 (0.45) HDAC6HDAC1HDAC3HDAC8HDAC2
SCHEMBL20242604 0.69 MTNR1A (0.56) HASPINLMNATP53RXFP1SNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8900565-B2 Indole derivatives as inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2014-12-02 US disclosed
US-20130156727-A1 INDOLE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130156727-A1 INDOLE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE HDAC8, HDAC1, HDAC2 HASPIN 403/4885PDPK1 841/4885CHEK2 1349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.